Abstract
Purpose
Positive margins are reported in from 4.8 to 9.5% of all gastric cancer surgeries and they have a negative impact on the overall survival. Few cases with positive duodenal margins have been included in previous studies regarding the prognosis.
Methods
This multi-institutional retrospective study included 115 gastric cancer patients with positive duodenal margins following gastrectomy between January 2002 and December 2017. The association between clinicopathological factors and the overall survival was evaluated by univariate and multivariate analyses.
Results
The three-year overall survival was 22% and the median survival was 13 months. A multivariate analysis found that distant metastasis, no postoperative chemotherapy, and non-Type 4 disease were significantly associated with a poor survival. Patients without distant metastasis who received postoperative chemotherapy had a 3-year overall survival of 56% and a median survival of 44 months.
Conclusion
The patients who underwent post-operative chemotherapy showed a significantly better OS compared with those who did not undergo post-operative chemotherapy, regardless of the existence of distant metastasis. Postoperative chemotherapy may, therefore, improve the prognosis of surgically treated gastric cancer patients with positive duodenal margins.
Similar content being viewed by others
References
van der Werf, Leonie R, Cords C, Arntz I, Belt EJT, Cherepanin IM, Coene PLO, et al. Population-based study on risk factors for tumor-positive resection margins in patients with gastric cancer. Ann Surg Oncol. 2019; 26:2222–2233.
Stiekema J, Stiekema J, Trip A, Trip A, Jansen E, Jansen E, et al. The prognostic significance of an R1 resection in gastric cancer patients treated with adjuvant chemoradiotherapy. Ann Surg Oncol. 2014;21:1107–14.
Raziee H, Raziee H, Cardoso R, Cardoso R, Seevaratnam R, Seevaratnam R, et al. Systematic review of the predictors of positive margins in gastric cancer surgery and the effect on survival. Gastric Cancer. 2012;15:116–24.
Li D, You J, Wang S, Zhou Y. Pancreaticoduodenectomy for locally advanced gastric cancer: results from a pooled analysis. Asian J Surg. 2019;42:477–81.
Tu R, Lin J, Wang W, Li P, Xie J, Wang J, et al. Pathological features and survival analysis of gastric cancer patients with positive surgical margins: a large multicenter cohort study. Eur J Surg Oncol. 2019;45:2457–64.
Wang S, Yeh C, Lee H, Liu Y, Chao T, Hwang T, et al. Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy. Ann Surg Oncol. 2009;16:2738–43.
Bickenbach K, Gonen M, Strong V, Brennan M, Coit D. Association of positive transection margins with gastric cancer survival and local recurrence. Ann Surg Oncol. 2013;20:2663–8.
Stiekema J, Stiekema J, Trip A, Trip A, Jansen E, Jansen E, et al. Does adjuvant chemoradiotherapy improve the prognosis of gastric cancer after an R1 resection? Results from a dutch cohort study. Ann Surg Oncol. 2015;22:581–8.
Chen J-, Yang X-, Shen J-, Hu W-, Yuan X-, Wang L. Prognostic improvement of reexcision for positive resection margins in patients with advanced gastric cancer. Eur J Surg Oncol. 2012; 39:229–234.
Konishi T, Takiguchi N, Soda H, Nagata M, Nabeya Y, Ikeda A, et al. Examination of the resection margin involvement after gastrectomy for gastric cancer (in Japanese with English abstract). Jpn J Gastroenterol Surg. 2013;46:317–24.
Anon. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–112.
Anon. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017; 20:1–19.
Luo Y, Gao P, Song Y, Sun J, Huang X, Zhao J, et al. Clinicopathologic characteristics and prognosis of Borrmann type IV gastric cancer: a meta-analysis. World J Surg Oncol. 2016;14:49–59.
Shiotani A. Gastric cancer. Singapore: Springer; 2018.
Ito S, Ohashi Y, Sasako M. Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial. BMC cancer. 2018;18:449.
Acknowledgement
This study was supported by investigators at eight hospitals (Toho University Ohashi Medical Center, Toho University Omori Medical Center, Japanese Red Cross Medical Center, University of Tokyo Hospital, The Jikei University Hospital, Showa University Hospital, National Hospital Organization Tokyo Medical Center, and NTT Medical Center Tokyo). We thank all the investigators of these institutions. We are deeply grateful to Yuko Okamura and Seiko Otsuka for their assistance in collecting the patient data.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Yoshinori Kikuchi, Yasuyuki Seto, Yoh Isobe and Hideaki Shimada received research grant and lecture fees from Taiho Pharmaceutical co. ltd. Yasuyuki Seto received research grant and lecture fees from Chugai Pharmaceutical co. ltd. The other authors have no conflicts of interest to declare in association with this study.
Ethical approval
The study protocol was approved by the Ethics Committee of the Faculty of Medicine, Toho University (#A19017, #A16084).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Fujita, S., Oshima, Y., Yajima, S. et al. What are the important prognostic factors in gastric cancer with positive duodenal margins? A multi-institutional analysis. Surg Today 51, 561–567 (2021). https://doi.org/10.1007/s00595-020-02110-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-020-02110-7